Undifferentiated carcinoma of the transverse colon with rhabdoid features that developed during treatment of non-small cell lung carcinoma with pembrolizumab: a case report

Abstract Background Undifferentiated carcinoma of the colon is rare, and its prognosis is very poor. We report a case of undifferentiated carcinoma of the colon with rhabdoid features developed during treatment of non-small lung carcinoma (NSCLC) with pembrolizumab. Case presentation A 58-year-old m...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuya Ashitomi, Mitsuhiro Yano, Michihisa Kono, Takefumi Suzuki, Ichiro Kawamura, Shinji Okazaki, Yukinori Kamio, Osamu Hachiya, Yuka Urano, Fuyuhiko Motoi
Format: Article
Language:English
Published: Japan Surgical Society 2020-08-01
Series:Surgical Case Reports
Subjects:
Online Access:http://link.springer.com/article/10.1186/s40792-020-00963-1
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849416114488999936
author Yuya Ashitomi
Mitsuhiro Yano
Michihisa Kono
Takefumi Suzuki
Ichiro Kawamura
Shinji Okazaki
Yukinori Kamio
Osamu Hachiya
Yuka Urano
Fuyuhiko Motoi
author_facet Yuya Ashitomi
Mitsuhiro Yano
Michihisa Kono
Takefumi Suzuki
Ichiro Kawamura
Shinji Okazaki
Yukinori Kamio
Osamu Hachiya
Yuka Urano
Fuyuhiko Motoi
author_sort Yuya Ashitomi
collection DOAJ
description Abstract Background Undifferentiated carcinoma of the colon is rare, and its prognosis is very poor. We report a case of undifferentiated carcinoma of the colon with rhabdoid features developed during treatment of non-small lung carcinoma (NSCLC) with pembrolizumab. Case presentation A 58-year-old man was diagnosed with transverse colon cancer during chemotherapy with pembrolizumab for NSCLC. Laparoscopic right hemicolectomy was performed. The histopathological diagnosis was undifferentiated carcinoma with rhabdoid features and lymph node metastasis. Immunohistochemically, programmed death ligand 1 (PD-L1) showed positivity. The microsatellite instability (MSI) status was low. He continued to receive pembrolizumab for NSCLC, and there have been no signs of colon cancer recurrence and progression of NSCLC for 15 months. Conclusion We present the case of an undifferentiated carcinoma of the transverse colon with rhabdoid features. The development of the tumor with the expression of PD-L1 during pembrolizumab might have been associated with the low MSI.
format Article
id doaj-art-2062e3f08b9f4ee2862aa375181f88eb
institution Kabale University
issn 2198-7793
language English
publishDate 2020-08-01
publisher Japan Surgical Society
record_format Article
series Surgical Case Reports
spelling doaj-art-2062e3f08b9f4ee2862aa375181f88eb2025-08-20T03:33:17ZengJapan Surgical SocietySurgical Case Reports2198-77932020-08-01611410.1186/s40792-020-00963-1Undifferentiated carcinoma of the transverse colon with rhabdoid features that developed during treatment of non-small cell lung carcinoma with pembrolizumab: a case reportYuya Ashitomi0Mitsuhiro Yano1Michihisa Kono2Takefumi Suzuki3Ichiro Kawamura4Shinji Okazaki5Yukinori Kamio6Osamu Hachiya7Yuka Urano8Fuyuhiko Motoi9First Department of Surgery, Yamagata University Faculty of MedicineFirst Department of Surgery, Yamagata University Faculty of MedicineFirst Department of Surgery, Yamagata University Faculty of MedicineFirst Department of Surgery, Yamagata University Faculty of MedicineFirst Department of Surgery, Yamagata University Faculty of MedicineFirst Department of Surgery, Yamagata University Faculty of MedicineFirst Department of Surgery, Yamagata University Faculty of MedicineFirst Department of Surgery, Yamagata University Faculty of MedicineDepartment of Pathological Diagnostics, Yamagata University Faculty of MedicineFirst Department of Surgery, Yamagata University Faculty of MedicineAbstract Background Undifferentiated carcinoma of the colon is rare, and its prognosis is very poor. We report a case of undifferentiated carcinoma of the colon with rhabdoid features developed during treatment of non-small lung carcinoma (NSCLC) with pembrolizumab. Case presentation A 58-year-old man was diagnosed with transverse colon cancer during chemotherapy with pembrolizumab for NSCLC. Laparoscopic right hemicolectomy was performed. The histopathological diagnosis was undifferentiated carcinoma with rhabdoid features and lymph node metastasis. Immunohistochemically, programmed death ligand 1 (PD-L1) showed positivity. The microsatellite instability (MSI) status was low. He continued to receive pembrolizumab for NSCLC, and there have been no signs of colon cancer recurrence and progression of NSCLC for 15 months. Conclusion We present the case of an undifferentiated carcinoma of the transverse colon with rhabdoid features. The development of the tumor with the expression of PD-L1 during pembrolizumab might have been associated with the low MSI.http://link.springer.com/article/10.1186/s40792-020-00963-1Colorectal cancerUndifferentiated carcinomaRhabdoid tumorPembrolizumab
spellingShingle Yuya Ashitomi
Mitsuhiro Yano
Michihisa Kono
Takefumi Suzuki
Ichiro Kawamura
Shinji Okazaki
Yukinori Kamio
Osamu Hachiya
Yuka Urano
Fuyuhiko Motoi
Undifferentiated carcinoma of the transverse colon with rhabdoid features that developed during treatment of non-small cell lung carcinoma with pembrolizumab: a case report
Surgical Case Reports
Colorectal cancer
Undifferentiated carcinoma
Rhabdoid tumor
Pembrolizumab
title Undifferentiated carcinoma of the transverse colon with rhabdoid features that developed during treatment of non-small cell lung carcinoma with pembrolizumab: a case report
title_full Undifferentiated carcinoma of the transverse colon with rhabdoid features that developed during treatment of non-small cell lung carcinoma with pembrolizumab: a case report
title_fullStr Undifferentiated carcinoma of the transverse colon with rhabdoid features that developed during treatment of non-small cell lung carcinoma with pembrolizumab: a case report
title_full_unstemmed Undifferentiated carcinoma of the transverse colon with rhabdoid features that developed during treatment of non-small cell lung carcinoma with pembrolizumab: a case report
title_short Undifferentiated carcinoma of the transverse colon with rhabdoid features that developed during treatment of non-small cell lung carcinoma with pembrolizumab: a case report
title_sort undifferentiated carcinoma of the transverse colon with rhabdoid features that developed during treatment of non small cell lung carcinoma with pembrolizumab a case report
topic Colorectal cancer
Undifferentiated carcinoma
Rhabdoid tumor
Pembrolizumab
url http://link.springer.com/article/10.1186/s40792-020-00963-1
work_keys_str_mv AT yuyaashitomi undifferentiatedcarcinomaofthetransversecolonwithrhabdoidfeaturesthatdevelopedduringtreatmentofnonsmallcelllungcarcinomawithpembrolizumabacasereport
AT mitsuhiroyano undifferentiatedcarcinomaofthetransversecolonwithrhabdoidfeaturesthatdevelopedduringtreatmentofnonsmallcelllungcarcinomawithpembrolizumabacasereport
AT michihisakono undifferentiatedcarcinomaofthetransversecolonwithrhabdoidfeaturesthatdevelopedduringtreatmentofnonsmallcelllungcarcinomawithpembrolizumabacasereport
AT takefumisuzuki undifferentiatedcarcinomaofthetransversecolonwithrhabdoidfeaturesthatdevelopedduringtreatmentofnonsmallcelllungcarcinomawithpembrolizumabacasereport
AT ichirokawamura undifferentiatedcarcinomaofthetransversecolonwithrhabdoidfeaturesthatdevelopedduringtreatmentofnonsmallcelllungcarcinomawithpembrolizumabacasereport
AT shinjiokazaki undifferentiatedcarcinomaofthetransversecolonwithrhabdoidfeaturesthatdevelopedduringtreatmentofnonsmallcelllungcarcinomawithpembrolizumabacasereport
AT yukinorikamio undifferentiatedcarcinomaofthetransversecolonwithrhabdoidfeaturesthatdevelopedduringtreatmentofnonsmallcelllungcarcinomawithpembrolizumabacasereport
AT osamuhachiya undifferentiatedcarcinomaofthetransversecolonwithrhabdoidfeaturesthatdevelopedduringtreatmentofnonsmallcelllungcarcinomawithpembrolizumabacasereport
AT yukaurano undifferentiatedcarcinomaofthetransversecolonwithrhabdoidfeaturesthatdevelopedduringtreatmentofnonsmallcelllungcarcinomawithpembrolizumabacasereport
AT fuyuhikomotoi undifferentiatedcarcinomaofthetransversecolonwithrhabdoidfeaturesthatdevelopedduringtreatmentofnonsmallcelllungcarcinomawithpembrolizumabacasereport